From the Journals

Primer message boosts colorectal cancer screening rates


 

FROM JAMA NETWORK OPEN

‘Good enhancement’ for health care systems

Reached for comment, Aasma Shaukat, MD, MPH, professor of medicine, NYU Langone Health, and first author of the American College of Gastroenterology (ACG) 2021 CRC screening guidelines, said the results are “interesting but not entirely surprising.”

“There’s literature supporting that a letter or notification prior to the FIT being mailed improves its uptake. Here, the authors applied it to their health care system in a quality improvement study and demonstrated it works,” Dr. Shaukat said.

“This is a good enhancement for health care systems where most of their patients are using or accessing their health chart portal,” added Dr. Shaukat.

“Caveats are that the generalizability is not known. It requires EHR [electronic health record] support tools and patients with access to a computer and enrolled and able to access their electronic chart, likely those with high literacy and English speaking.”

Funding for the study was provided by the UCLA Health Department of Medicine. Dr. Goshgarian, Dr. Croymans, and Dr. Shaukat have disclosed no relevant financial relationships.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

Donafenib shows potential as first-line treatment of advanced hepatocellular carcinoma
AVAHO
'Deep learning' AI shows benefit in colonoscopy in U.S. population
AVAHO
Tracking adenomas per colonoscopy shows promise as quality measure
AVAHO
Antibiotic and glucocorticoid use before cancer therapy could have detrimental effect on outcomes
AVAHO
Obesity interventions tied to colon cancer risk reduction
AVAHO
Endoscopic resection of esophageal cancer requires long-term post-op surveillance
AVAHO
Colorectal cancer rates rising in people aged 50-54 years
AVAHO
US Multi-Society Task Force lowers recommended CRC screening age
AVAHO
Can immunotherapy replace surgery for stomach cancer?
AVAHO
Improved follow-up needed to find late-stage pancreatic cancers
AVAHO